Notably, EBV-induced NPC, characterized by overexpression of programmed cell death-ligand 1 (PD-L1) and significant lymphocyte infiltration, shows promise as a candidate for immunotherapy7. The gene discussed is CD274; the disease is nasopharyngeal carcinoma.